Aggravating influence of atomoxetine on the severity of stuttering and its successful treatment with methylphenidate: a case report

Stuttering is a communication disorder characterized by a disruption in normal fluency and time patterning of speech. None of the pharmacological agents for stuttering could be recommended for general use; specific drug treatment that is simultaneously effective for both stuttering and attention deficit hyperactivity disorder (ADHD) is currently unknown. In this article, we present a case affected by severe developmental stuttering and ADHD that was exacerbated by atomoxetine but favorably responded to treatment with methylphenidate.

___

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Fifth ed., Washington, DC: American Psychiatric Association, 2013.

2. Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock’s synopsis of psychiatry, behavioral sciences/clinical psychiatry. Eleventh Ed. Philadelphia: Wolters Kluwer, 2015; 1147-1149.

3. Donaher J, Richels C. Traits of attention deficit/hyperactivity disorder in school-age children who stutter. J Fluency Disord 2012; 37:242-252.

4. Maguire GA, Yu BP, Franklin DL, Riley GD. Alleviating stuttering with pharmacological interventions. Expert Opin Pharmacother 2004; 5:1565-1571.

5. Devroey D, Beerens G, Van De Vijver E. Methylphenidate as a treatment for stuttering: a case report. Eur Rev Med Pharmacol Sci 2012; 16:66-69.

6. Rabaeys H, Bijleveld HA, Devroey D. Influence of methylphenidate on the frequency of stuttering: a randomized controlled trial. Ann Pharmacother 2015; 49:1096-1104.

7. Bodur S, Isildar Y, Kara H, Sabanci M. Effectiveness of osmoticcontrolled release oral delivery system methylphenidate in the treatment of stuttering that combined with attention-deficit/ hyperactivity disorder: a case report. Am J Psychiatry Neurosci 2014; 2:115-117.

8. Copur M, Copur S. Emergence of stuttering in an attention deficit hyperactivity disorder patient treated with methylphenidate. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2018; 31:222-224.

9. Alpaslan AH, Coskun KŞ, Kocak U, Gorucu Y. Stuttering associated with the use of short-acting oral methylphenidate. J Clin Psychopharmacol 2015; 35:739-741.

10. Donaher J, Healey EC, Zobell A. The effects of ADHD medication changes on a child who stutters. Perspect Fluen Fluen Disord 2009; 19:95-98.

11. Zhou J. Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future 2004; 29:1235-1244.

12. Kratochvil CJ, Vaughan BS, Harrington MJ, Burke WJ. Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Pharmacother 2003; 4:1165-1174.

13. Morón JA, Brockington A, Wise RA, Rocha BA, Hope BT. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 2002; 22:389-395.
Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi-Cover
  • ISSN: 1018-8681
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1984
  • Yayıncı: Kare Yayıncılık
Sayıdaki Diğer Makaleler

Evaluation of domestic physical violence in a male sample in a psychiatric outpatient clinic: a controlled study

Vahap KARABULUT, Başak ÖZÇELİK, Oğuz KARAMUSTAFALIOĞLU

Acute stress disorder with panic episodes induced by exposure to COVID-19 outbreak news in a child

Duygu KABA, Burcu AKİN SARİ

Measuring coronaphobia: the psychological basis of the Coronavirus Anxiety Scale

Sherman A. LEE

Rapid efficacy of mirtazapine in the treatment of hyperemesis gravidarum with esophagus perforation and ketonuria in a normoglycemic patient: a case report

Aysegul TASDELEN KUL, Ibrahim GUNDOGMUS, Mikail Burak AYDİN

The associations of temperament, character, anxiety, and specialty choice among sixth-year medical students: a cross-sectional study

Erhan AKINCI

Validity and reliability of the Benevolent Childhood Experiences (BCEs) Scale in Turkish

Rumeysa Gunay OGE, Fatmatuz Zehra PEHLİVAN, Sedat IŞIKLI

Monocyte-to-lymphocyte ratio and platelet-tolymphocyte ratio in opioid use disorder and marijuana use disorder

Mehmet Hamdi ORUM, Mahmut Zabit KARA

The relationship between perceived stress, dissociative experiences, depressive symptoms, and anxiety sensitivity in borderline personality disorder

Mehmet Emin DEMİRKOL, Lut TAMAM, Soner ÇAKMAK, Kerim UĞUR, Caner YESİLOĞLU

Substance use patterns, psychosocial traumas, psychiatric comorbidities, and gender differences among adolescent inpatients at an addiction treatment center

Deniz YILDIZ, Arzu ÇİFTÇİ, Özhan YALÇIN

Hiccups associated with switching from quetiapine to aripiprazole in an adolescent patient

Mert BEŞENEK